Prognostic Value of the CONUT Score in Predicting All-Cause Mortality in Hospitalized Internal Medicine Patients: A

Betül Çavuşoğlu Türker1, Mehmet Yamak1, Mehmet Çetin1

  • 1Department of İnternal Medicine, University of Health Sciences Turkey, Haseki Health Training and Research Hospital, Aksaray, Dr. Adnan Adıvar Cd. No: 9, 34130 Istanbul, Turkey.

PubMed

Insights

The CONUT score, a simple nutritional index, strongly predicts mortality in hospitalized patients. Higher CONUT scores indicate increased all-cause mortality risk, aiding early identification of high-risk individuals.

Area of Science:

  • Internal Medicine
  • Clinical Nutrition
  • Prognostic Biomarkers

Background:

  • Assessing mortality risk in hospitalized patients is crucial for clinical management.
  • The CONUT (Controlling Nutritional Status) score is a readily available nutritional index.
  • Limited data exist on the prognostic significance of the CONUT score in internal medicine wards.

Purpose of the Study:

  • To evaluate the prognostic significance of the CONUT score.
  • To assess the association between the CONUT score and all-cause mortality.
  • To identify independent predictors of mortality in hospitalized internal medicine patients.

Main Methods:

  • Retrospective cohort study of hospitalized adult internal medicine patients.
  • CONUT score calculated using serum albumin, total cholesterol, and lymphocyte count.
  • Survival analysis using Cox proportional hazards regression, with multivariate analysis for independent predictors.

Main Results:

  • The CONUT score demonstrated a significant association with all-cause mortality.
  • CONUT score, age, chronic renal disease, and solid organ malignancy were independent predictors of mortality.
  • Each one-point increase in CONUT score nearly doubled the risk of death (HR = 1.219).

Conclusions:

  • The CONUT score is a powerful and independent predictor of all-cause mortality in hospitalized internal medicine patients.
  • Its simplicity and low cost facilitate integration into routine clinical practice.
  • CONUT aids in early risk stratification and identifying patients for closer monitoring and nutritional support.

Related Concept Videos

Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
963
Life Tables01:22

Life Tables

A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
693
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
396
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
807
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
734
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
870